Crestchem Ltd (CRSTCHM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Crestchem Ltd on NSE and BSE, with an AI summary of each filing.
Crestchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve This is to bring to your kind notice ....
Intimation · 05 Nov 2026, 5:30 am
Crestchem Schedules Board Meeting on 5th Nov'26 to Consider Q2 Results Crestchem Limited has informed BSE that its Board of Directors will meet on 5th Nov'26 at 3:40 PM. The board will consider, approve, and take on record the company's unaudited standalone and consolidated financial results, along with the limited review report, for the quarter and half-year ended 30th Sep'26.
Dear Sir, This is with reference to your above referred letter received by us vide email dated October 14, 2026 reference no. L/SURV/ONL/PV/SJ/ 2026-2027 / 4382 dated 14/10/2026 seeking ....
Others (Uncategorized) · 16 Oct 2026, 5:32 pm
Crestchem Clarifies Recent Share Price Movement is Purely Market-Driven Crestchem Limited clarified to BSE on 15th Oct'26 that it has no undisclosed material information, pending announcements, or events under Regulation 30 of SEBI LODR Regulations impacting operational or financial performance. The company stated that recent stock price fluctuations are entirely market-driven based on prevailing trading conditions. Furthermore, all promoters, directors, key managerial personnel, and designated employees comply with SEBI Prohibition of Insider Trading Regulations and have no connection to the price movement.
The Exchange has sought clarification from Crestchem Ltd on October 14, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Others (Uncategorized) · 14 Oct 2026, 11:39 pm
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform that the Board of Directors of ....
Change in Management · 08 Sept 2026, 10:29 pm
Crestchem Appoints Indrajyotsingh Ranjitsingh Bagga as Compliance Officer Crestchem Limited announced that its Board of Directors approved the appointment of Mr. Indrajyotsingh Ranjitsingh Bagga as Compliance Officer and Assistant Company Secretary, effective 8th Sep'26. Mr. Bagga, a qualified Company Secretary (Membership No. A81745) and B.Com graduate pursuing an LL.B., will oversee compliance under SEBI Listing Regulations, Insider Trading Regulations, Companies Act, 2013, IBC, and FEMA.
Crestchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/09/2026 ,inter alia, to consider and approve Appointment of Assistant Company ....
Intimation · 03 Sept 2026, 6:56 pm
Crestchem Limited Board Meeting for Compliance Officer Appointment Crestchem Limited announced a Board of Directors meeting scheduled for 8th Sep'26. The primary agenda is to consider and approve the appointment of Mr. Indrajyot Bagga as the new Assistant Company Secretary and Compliance Officer, effective 8th Sep'26.
Please refer to our earlier letter dated Friday, August 07,2026, wherein we have intimated the convening of our board meeting on Wednesday August 12, 2026 for consideration and approval ....
Outcome · 12 Aug 2026, 10:21 pm
Crestchem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 926 (-9.5% QoQ) ■ EBITDA: 114 (-18.3% QoQ) ■ EBITDA Margin (%): 12.3 (-134 bps QoQ) ■ PAT: 94.2 (-14.7% QoQ) ■ EPS (INR): 3.14 (-14.4% QoQ)
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a summary of proceedings of the 34th Annual General Meeting ....
Annual General Meeting · 08 Aug 2026, 4:57 pm
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Voting Results of the resolutions transacted ....
Annual General Meeting · 07 Aug 2026, 8:05 pm
Crestchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Dear sir, This is to bring to your ....
Intimation · 12 Aug 2026, 5:30 am
Crestchem Board Meeting on 12th Aug'26 to Approve Q1 Results Crestchem Limited has scheduled a Board of Directors meeting on 12th Aug'26 to approve unaudited standalone and consolidated financial results for the quarter ended 30th Jun'26. The agenda also includes taking note of a fine imposed by the BSE. This penalty relates to the late submission of a consolidated cash flow statement following the registration of a new subsidiary on 31st Mar'26. The meeting will address any other items with the Chair's permission.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a summary of proceedings of the 34th Annual General Meeting ....
Annual General Meeting · 06 Aug 2026, 8:31 pm
Pursuant to the provisions of Regulation 30 read with Schedule III of SEBI Listing Regulations, please find below the details as required under Clause 20 of Para A of Part A of Schedule ....
Others (Uncategorized) · 04 Aug 2026, 10:43 pm
Crestchem Fined by BSE for Late Submission of Financials Crestchem Limited received an email from BSE on 4th Aug'26 imposing an outstanding fine of ₹106,200. This was for the late submission of the consolidated Cash Flow Statement under SEBI Regulation 33. The company stated its subsidiary, Oleo Biosciences, was incorporated on 31st Mar'26 and had no financial transactions, thus no data was required for the consolidated statement. Crestchem is positive it will receive a waiver for the fine and anticipates no material financial impact from this event.
Dear Sir, This is to inform you that Record Date for Payment of Dividend @15% Rs.1.50 per Shares is fixed on Thursday July 30, 2026. Nitin S.Shah Company Secretary & Compliance Officer
Dividend · 16 Jul 2026, 7:23 pm
Crestchem Sets Record Date for FY25-26 Dividend Crestchem Limited has set Thursday, Jul 30, '26, as the record date for its FY25-26 dividend. The Board of Directors approved a dividend of 15%, equivalent to Rs. 1.50 per equity share. Shareholders on record as of the cut-off date will be entitled to receive the payment. The decision was finalized during the board meeting held on Jul 04, '26.
Please find attached the ESCROW PAYMENT MECHANISUM which is not applicable to our Company. Nitin S.Shah
Others (Uncategorized) · 15 Jul 2026, 8:22 pm
Crestchem Confirms Inapplicability of Escrow Payment Mechanism Crestchem Limited (Scrip Code: 526269) informed BSE on 15-Jul'26 that the Escrow Payment Mechanism is not applicable to the company. The filing confirmed that it holds no such accounts, specifically stating the non-existence of a No Lien escrow account, Interest Payment Account, Sinking Fund Account, or General Account related to this mechanism.
Dear Sir, Please find the certificate for ESCROW PAYMENT MECHANISUM. Nitin S.Shah Company Secretary
Others (Uncategorized) · 15 Jul 2026, 8:18 pm
Crestchem Confirms Escrow Payment Mechanism Not Applicable Crestchem Limited (Scrip Code: 526269) informed BSE on 15-Jul'26 that the Escrow Payment Mechanism is not applicable to the company. It confirmed the non-existence of specific accounts related to this mechanism, including No Lien escrow, Interest Payment, Sinking Fund, and General accounts. This regulatory filing clarifies the company's financial structure regarding such arrangements for investor information and record purposes.
Dear Sir, Please find attached Annual Report -2025-26 of CRESTCHEM LIMITED . Thanking You. Nitin S.Shah Company Secretary & Compliance Officer
Others (Uncategorized) · 13 Jul 2026, 9:11 pm
Revised outcome with Declaration
Revision of outcome · 04 Jul 2026, 8:20 pm
Crestchem Q4FY26 Results: PAT Flat YoY; Recommends ₹1.50 Dividend Crestchem reported Q4FY26 standalone PAT at ₹110.38 Lacs, up 80.8% YoY. Full-year FY26 PAT was ₹271.35 Lacs, largely flat vs. FY25. Revenue from operations for FY26 grew 18.1% YoY to ₹2,960.74 Lacs. The Board recommended a final dividend of ₹1.50 per share (15%) for FY26. Additionally, the Board approved an investment of up to ₹2.25 Crores in its newly incorporated subsidiary, Oleo Biosciences Private Limited, and noted the subsidiary had not commenced operations as of 31 Mar'26.
Outcome of Board Meeting for 34th Annual General Meeting and related their approvals
Outcome · 04 Jul 2026, 8:03 pm
Crestchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/07/2026 ,inter alia, to consider and approve AGM and other matters. Nitin S.Shah
Intimation · 27 Jun 2026, 9:47 pm
Dear Sir, Disclosure under regulation 7(2) of SEBI (PIT) Regulations, 2015 Sale of Equity Shares by Promoter Dipak N.Patel relative his Sister Sonal Dushyant Patel for more than Rs.10 ....
Others (Uncategorized) · 24 Jun 2026, 6:15 pm
Crestchem Promoter Group Member Sells Equity Shares in Open Market Ms. Sonal Dushyant Patel, a promoter group member (Sister of Promoter), sold 9,305 equity shares of Crestchem Limited through open market transactions on 23-Jun-26. This disposal reduced her holding from 14,600 shares (0.48% stake) to 5,295 shares. The total value of the shares sold was ₹1,296,822. The company was intimated of this transaction on 24-Jun-26, as per SEBI's insider trading regulations.
Dear Sir, Announcement by Sonal Dushyant Patel to sale of her Shareholding of 14600 Equity Shares in Crestchem Limited.
Others (Uncategorized) · 23 Jun 2026, 8:00 pm
Crestchem Promoter Group Member Announces Intent to Sell Stake Ms. Sonal Dushyant Patel, a member of Crestchem's promoter group, disclosed her intent to sell 14,600 equity shares via open market transactions. This was followed by a separate disclosure on 23-Jun-26 confirming the sale of 6,805 shares for ₹947,379 on 22-Jun-26. Post-transaction, her holding reduced from 14,600 shares (0.48% stake) to 7,795 shares. The initial filing indicated an intention to sell the entire 14,600-share block, though only a partial sale has been executed and reported so far.
Revised outcome
Revision of outcome · 19 Jun 2026, 10:03 pm
Crestchem Reports Q4FY26 Results and Declares ₹1.50/Share Final Dividend Crestchem Limited reported Q4FY26 standalone net profit of ₹110.38 Lacs, up 80.8% YoY. Revenue from operations grew 41.4% YoY to ₹1,022.53 Lacs. For FY26, net profit was stable at ₹271.35 Lacs versus ₹272.65 Lacs in FY25. The Board recommended a final dividend of ₹1.50 per share (15%) for FY26, subject to shareholder approval. The company also incorporated a new subsidiary, Oleo Biosciences Private Limited, on 31 Mar'26 and approved an investment of up to ₹2.25 Crores in it.
Revised outcome
Revision of outcome · 19 Jun 2026, 10:02 pm
Crestchem Q4 FY26 Results: Net Profit Surges 81% YoY, Board Recommends Dividend Crestchem reported strong standalone results for Q4 FY26, with net profit surging 80.8% YoY to Rs. 110.38 Lacs. Revenue from operations grew 41.4% YoY to Rs. 1,022.53 Lacs. For the full year FY26, net profit was Rs. 271.35 Lacs, a slight decrease from Rs. 272.65 Lacs in FY25, while revenue rose 18.1% to Rs. 2,960.74 Lacs. The Board recommended a final dividend of Rs. 1.50 per share (15%). The company also approved an investment up to Rs. 2.25 Crores in its newly incorporated subsidiary, Oleo Biosciences.
Dear Sir, Please find attached Newspaper Cutting For Audited Financial Results for the year ended 31st March,2026
Others (Uncategorized) · 01 Jun 2026, 5:55 pm
Crestchem Ltd Reports FY26 Audited Consolidated Financial Results Crestchem reported FY26 consolidated results with total income from operations at ₹2,960.74 Lakhs, a 16.2% YoY increase from ₹2,547.05 Lakhs in FY25. Net profit after tax grew 17.1% YoY to ₹331.70 Lakhs from ₹283.35 Lakhs. Basic and diluted EPS stood at ₹5.00 for FY26, up from ₹4.27 in the previous year. For Q4FY26, net profit was ₹103.20 Lakhs on an income of ₹1,022.15 Lakhs, with an EPS of ₹1.56.
The Board Considered 15% dividend on its Board Meeting held on 29th May,2026. Nitin S.Shah
Dividend · 01 Jun 2026, 5:38 pm
Crestchem Q4FY26 Results: Net Profit Surges YoY; Final Dividend Recommended Crestchem reported a standalone net profit of Rs. 110.38 Lacs for Q4FY26, an 80.8% YoY increase. Revenue from operations grew 41.4% YoY to Rs. 1,022.53 Lacs. For the full year FY26, net profit was Rs. 271.35 Lacs, nearly flat YoY, on revenue of Rs. 2,960.74 Lacs, up 18.1% YoY. The Board recommended a final dividend of Rs. 1.50 per share (15%). The company also approved an investment up to Rs. 2.25 Crores in its newly incorporated subsidiary, Oleo Biosciences.
Board has considered and adopted Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March,2026 and Recommended 15% dividend for the financial year 2025-26
Outcome · 29 May 2026, 9:42 pm
Crestchem Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lacs) ■ Revenue: 1,023 (+41.4% YoY | +42.8% QoQ) ■ EBITDA: 140 (+131.9% YoY | +73.7% QoQ) ■ EBITDA Margin (%): 13.7 (+534 bps YoY | +243 bps QoQ) ■ PAT: 110 (+80.8% YoY | +53.9% QoQ) ■ EPS (INR): 3.67 (+80.8% YoY | +53.6% QoQ)